The Medicines Company Announces Chief Financial Officer Transition
March 27 2018 - 8:05PM
Business Wire
The Medicines Company (NASDAQ: MDCO) today announced the
appointment of Christopher Visioli as Chief Financial Officer and
Treasurer of the Company, effective immediately. Mr. Visioli
succeeds William B. O’Connor, who is retiring from the Company
after serving as Chief Accounting Officer and then Chief Financial
Officer for a total of 13 years. Mr. O’Connor will remain with the
Company as an advisor through 2018, assisting Mr. Visioli in
transition and completing the close-out of the Company’s non-core
businesses and products. Mr. Visioli will report directly to Clive
Meanwell, M.D., Ph.D., Chief Executive Officer of The Medicines
Company.
“Chris brings extensive leadership experience and broad
operational expertise developed over a long and successful career
at The Medicines Company,” Dr. Meanwell said. “Chris will play an
important role as we continue to successfully execute on our
strategic plan. I know that the Company will benefit from his
expertise, insight and experience, and I and the rest of the
Company’s Board of Directors look forward to working with him. In
addition, I would like to personally thank Bill for his
contributions to the Company over more than a decade of successful
service. Bill will continue to serve as an advisor as we wind down
our legacy businesses, and I wish him luck in his retirement upon
conclusion of this important work.”
Mr. Visioli previously served as Senior Vice President,
Financial Strategy, of the Company from January 2015 to March 2018,
and Vice President, Cardiovascular Care, from January 2013 to
December 2014. Mr. Visioli joined the Company in June 2003 and has
served in a variety of leadership roles in the organization,
including finance, business development, investor relations,
strategy, planning, and business leadership of the Cardiovascular
Care business unit. Prior to joining the Company, Mr. Visioli was a
management consultant at Ernst & Young. Mr. Visioli holds a
Bachelor’s Degree in electrical engineering from Cornell University
and an M.B.A. from Columbia Business School.
About The Medicines Company
The Medicines Company is a biopharmaceutical company driven by
an overriding purpose - to save lives, alleviate suffering and
contribute to the economics of healthcare. The Company’s mission is
to create transformational solutions to address the most pressing
healthcare needs facing patients, physicians and providers in
cardiovascular care. The Company is headquartered in Parsippany,
New Jersey.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180327006435/en/
Investor RelationsThe
Medicines CompanyKrishna Gorti, M.D.Vice President, Investor
Relations(973) 290-6122krishna.gorti@themedco.com
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Apr 2023 to Apr 2024